{"id":13385,"date":"2021-03-01T13:12:13","date_gmt":"2021-03-01T12:12:13","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=13385"},"modified":"2025-02-26T15:52:24","modified_gmt":"2025-02-26T14:52:24","slug":"edito-par-celine-pulcini","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/","title":{"rendered":"\u00c9dito par C\u00e9line Pulcini"},"content":{"rendered":"\n

La Feuille de route interminist\u00e9rielle pour la ma\u00eetrise de l\u2019antibior\u00e9sistance<\/a>, publi\u00e9e en 2016, comporte 40 actions, dans une perspective \u00ab Une seule sant\u00e9 \u00bb (\u00ab One Health<\/em> \u00bb approche globale pr\u00f4n\u00e9e par l\u2019OMS \u2013 l\u2018Organisation Mondiale de la Sant\u00e9 \u2013 et l\u2019OIE \u2013 l\u2019Organisation mondiale de la sant\u00e9 animale). Elle mobilise sept minist\u00e8res et de nombreuses agences et instances nationales. Pour le volet sant\u00e9 humaine, un rapport annuel<\/a> synth\u00e9tisant les actions men\u00e9es est publi\u00e9 tous les ans depuis 2019. Un document court, disponible en fran\u00e7ais et en anglais et r\u00e9sumant quelques mesures innovantes<\/a>, para\u00eet \u00e9galement tous les ans depuis 2019 au mois de mai, lors de l\u2019Assembl\u00e9e mondiale de la Sant\u00e9 de l\u2019OMS. Tous ces documents sont t\u00e9l\u00e9chargeables sur l\u2019espace antibiotiques.gouv.fr<\/a> du site du minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9.<\/p>\n\n\n\n

De nombreuses actions sont men\u00e9es pour la pr\u00e9vention et le contr\u00f4le des infections, notamment associ\u00e9es aux soins, ainsi que le bon usage des antibiotiques. La dimension recherche n\u2019est pas en reste, avec la participation de la France aux programmes de recherche europ\u00e9ens comme le JPIAMR<\/a> et la pr\u00e9sence d\u2019un Programme prioritaire de recherche (PPR) national d\u00e9di\u00e9 \u00e0 l\u2019antibior\u00e9sistance, dot\u00e9 de 40 millions d\u2019euros sur 10 ans.<\/p>\n\n\n\n

Concernant le volet Innovation (nouveaux produits luttant contre l\u2019antibior\u00e9sistance), un Contrat strat\u00e9gique de fili\u00e8re des industries de sant\u00e9 d\u00e9di\u00e9 \u00e0 l\u2019antibior\u00e9sistance permet d\u2019\u00e9changer sur ce sujet entre industriels et pouvoirs publics depuis f\u00e9vrier 2019. La Strat\u00e9gie pharmaceutique de l\u2019Union europ\u00e9enne<\/a>, publi\u00e9e en novembre 2020, inclut \u00e9galement le sujet des nouveaux antibiotiques dans son programme de travail.<\/p>\n\n\n\n

Toutes ces activit\u00e9s recherche et innovation en lien avec la th\u00e9matique de l\u2019antibior\u00e9sistance b\u00e9n\u00e9ficient d\u00e9sormais d\u2019une large visibilit\u00e9 au sein de cette interface nationale Antibior\u00e9sistance coordonn\u00e9e par l\u2019Inserm, et je m\u2019en r\u00e9jouis.<\/p>\n\n\n\n

La France est \u00e9galement engag\u00e9e pour garantir la disponibilit\u00e9 des antibiotiques existants essentiels. Le minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9 coordonne depuis 2019 une feuille de route visant \u00e0 lutter contre les p\u00e9nuries de m\u00e9dicaments, dont les antibiotiques. Lanc\u00e9 en novembre 2020 pour une dur\u00e9e de trois ans, le Programme d\u2019appui \u00e0 la r\u00e9forme structurelle<\/a> (PARS) marque \u00e9galement l\u2019engagement du Gouvernement fran\u00e7ais pour assurer la disponibilit\u00e9 des antibiotiques. Ce PARS est un projet cofinanc\u00e9 par l\u2019Union europ\u00e9enne et vise une approche \u00ab Une seule sant\u00e9 \u00bb ou \u00ab One Health<\/em> \u00bb, en sant\u00e9 humaine, sant\u00e9 animale et environnement. L\u2019objectif du projet est d\u2019identifier et de mettre en \u0153uvre en France des mesures pilotes pour s\u2019attaquer aux causes profondes du probl\u00e8me de p\u00e9nurie et de manque de disponibilit\u00e9 des antibiotiques utilis\u00e9s en m\u00e9decines humaine et v\u00e9t\u00e9rinaire dont le brevet est tomb\u00e9 dans le domaine public, tout en prot\u00e9geant l\u2019environnement et en tenant compte des contextes r\u00e9glementaires europ\u00e9en et national.<\/p>\n\n\n\n

La direction g\u00e9n\u00e9rale de l\u2019appui aux r\u00e9formes structurelles de la Commission europ\u00e9enne (DG REFORM) et l\u2019OMS apporteront leur assistance technique au Gouvernement fran\u00e7ais avec la participation de cinq minist\u00e8res et de deux agences nationales. Le sujet des p\u00e9nuries de m\u00e9dicaments va \u00e9galement \u00eatre discut\u00e9 dans le cadre de la Strat\u00e9gie pharmaceutique de l\u2019Union europ\u00e9enne.<\/p>\n\n\n\n

Toutes les actions men\u00e9es depuis de nombreuses ann\u00e9es par les pouvoirs publics et les acteurs de terrain pour lutter contre l\u2019antibior\u00e9sistance semblent commencer \u00e0 porter leurs fruits en France, avec une tendance r\u00e9cente \u00e0 la baisse des consommations d\u2019antibiotiques et de certaines r\u00e9sistances bact\u00e9riennes en ville et en \u00e9tablissements de sant\u00e9 pour la sant\u00e9 humaine et une r\u00e9duction nette des usages antibiotiques et de l\u2019antibior\u00e9sistance en sant\u00e9 animale. Ces efforts n\u00e9cessitent cependant d\u2019\u00eatre poursuivis et intensifi\u00e9s. L\u2019interface nationale antibior\u00e9sistance sera, j\u2019en suis convaincue, un formidable outil pour faciliter l\u2019acc\u00e8s \u00e0 l\u2019information et les collaborations en recherche sur la th\u00e9matique de l\u2019antibior\u00e9sistance.<\/p>\n\n\n\n

Lutter contre l\u2019antibior\u00e9sistance n\u00e9cessite l\u2019implication de tous et j\u2019esp\u00e8re pouvoir compter sur votre engagement et votre mobilisation.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n\n\n\n
<\/div>\n\n\n\n

Autrice<\/h3>\n\n\n\n
\"\"<\/figure>
\n

Pr C\u00e9line PULCINI<\/strong><\/p>\n\n\n\n

Cheffe de projet national \u00e0 l\u2019antibior\u00e9sistance<\/em><\/p>\n\n\n\n

Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9<\/strong><\/p>\n<\/div><\/div>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

La Feuille de route interminist\u00e9rielle pour la ma\u00eetrise de l\u2019antibior\u00e9sistance, publi\u00e9e en 2016, comporte 40 actions, dans une perspective \u00ab Une seule sant\u00e9 \u00bb (\u00ab One Health \u00bb approche globale pr\u00f4n\u00e9e par l\u2019OMS \u2013 l\u2018Organisation Mondiale de la Sant\u00e9 \u2013 et l\u2019OIE \u2013 l\u2019Organisation mondiale de la sant\u00e9 animale). Elle mobilise sept minist\u00e8res et de nombreuses agences et instances nationales. Pour le […]<\/p>\n","protected":false},"author":1,"featured_media":30160,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[3341],"tags":[],"acf":[],"yoast_head":"\n\u00c9dito par C\u00e9line Pulcini - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00c9dito par C\u00e9line Pulcini - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-01T12:12:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-26T14:52:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/Celine-Pulcini.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"892\" \/>\n\t<meta property=\"og:image:height\" content=\"1152\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Emmanuel Auchet\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Emmanuel Auchet\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/\"},\"author\":{\"name\":\"Emmanuel Auchet\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/dddace6035f5329dbab637f17f7a1ff8\"},\"headline\":\"\u00c9dito par C\u00e9line Pulcini\",\"datePublished\":\"2021-03-01T12:12:13+00:00\",\"dateModified\":\"2025-02-26T14:52:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/\"},\"wordCount\":754,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/Celine-Pulcini.jpg\",\"articleSection\":[\"Editoriaux\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/\",\"name\":\"\u00c9dito par C\u00e9line Pulcini - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/Celine-Pulcini.jpg\",\"datePublished\":\"2021-03-01T12:12:13+00:00\",\"dateModified\":\"2025-02-26T14:52:24+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/Celine-Pulcini.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/Celine-Pulcini.jpg\",\"width\":892,\"height\":1152},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Editoriaux\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"\u00c9dito par C\u00e9line Pulcini\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/dddace6035f5329dbab637f17f7a1ff8\",\"name\":\"Emmanuel Auchet\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u00c9dito par C\u00e9line Pulcini - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/","og_locale":"fr_FR","og_type":"article","og_title":"\u00c9dito par C\u00e9line Pulcini - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2021-03-01T12:12:13+00:00","article_modified_time":"2025-02-26T14:52:24+00:00","og_image":[{"width":892,"height":1152,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/Celine-Pulcini.jpg","type":"image\/jpeg"}],"author":"Emmanuel Auchet","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Emmanuel Auchet","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/"},"author":{"name":"Emmanuel Auchet","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/dddace6035f5329dbab637f17f7a1ff8"},"headline":"\u00c9dito par C\u00e9line Pulcini","datePublished":"2021-03-01T12:12:13+00:00","dateModified":"2025-02-26T14:52:24+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/"},"wordCount":754,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/Celine-Pulcini.jpg","articleSection":["Editoriaux"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/","name":"\u00c9dito par C\u00e9line Pulcini - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/Celine-Pulcini.jpg","datePublished":"2021-03-01T12:12:13+00:00","dateModified":"2025-02-26T14:52:24+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/Celine-Pulcini.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/Celine-Pulcini.jpg","width":892,"height":1152},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-celine-pulcini\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Editoriaux","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/"},{"@type":"ListItem","position":3,"name":"\u00c9dito par C\u00e9line Pulcini"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/dddace6035f5329dbab637f17f7a1ff8","name":"Emmanuel Auchet"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-18 20:52:48","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/13385"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=13385"}],"version-history":[{"count":8,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/13385\/revisions"}],"predecessor-version":[{"id":30167,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/13385\/revisions\/30167"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media\/30160"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=13385"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=13385"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=13385"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}